Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Board Member
Galectin Therapeutics Inc (GALT)Equibles does not estimate personal net worth.
Get an email with a short summary when Galectin Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get GALT alertsJoel Lewis is recorded as Board Member at Galectin Therapeutics Inc (GALT) since January 1, 2017 and CEO at Galectin Therapeutics Inc (GALT). The newest filing on record that lists Joel Lewis as CEO and Board Member at Galectin Therapeutics Inc (GALT) is dated October 13, 2026. The proxy statement of Galectin Therapeutics Inc reports total compensation of $1,174,782 for Joel Lewis in fiscal 2025, including a base salary of $624,000. Disclosed compensation is on record for 6 fiscal years. Joel Lewis has spoken on 1 investor event across 1 company, most recently for Galectin Therapeutics Inc on September 14, 2026. Galectin Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Galectin Therapeutics Inc includes Jack W. Callicutt (CFO), Benjamin S. Carson (Board Member), Dr. Henry Brem (Board Member) and 7 others.
“On behalf of Galactin Therapeutics, I'm pleased to provide an update on our clinical development program and share an update on our path forward as we are preparing for our phase three registration trial.”
2017-01-01–present
Last confirmed October 13, 2026
Start not stated–present
Last confirmed October 13, 2026
Biotechnology · Healthcare
CEO, Board Member
2017-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $624,000 | $1,174,782 |
| 2024 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $620,167 | $1,189,674 |
| 2023 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $573,583 | $963,647 |
| 2022 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $522,917 | $974,181 |
| 2021 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $500,000 | $1,167,621 |
| 2020 | Galectin Therapeutics Inc (GALT) | Chief Executive Officer & President | $164,773 | $753,558 |